Gerardo Altamura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gerardo Altamura has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Gianfranco Damiani
Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy
8 shared publications - Mario Cesare Nurchis
Affiliations Department of Life Science, Health, and Health Professions, Università degli Studi Link, Rome, Italy, Department of Health Science and Public Health, Section of Hygiene, Università Cattolica del Sacro Cuore, Rome, Italy
6 shared publications Mario Cesare Nurchis
Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
4 shared publicationsAnnarita Panebianco
Medical Management, IDI‐IRCCS ‐ FLMM Rome Italy
3 shared publicationsG Damiani
Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore , Rome, Italy
3 shared publications- Gian Marco Raspolini
Section of Hygiene, Department of Health Science and Public Health, Università Cattolica del Sacro Cuore, Rome - Italy
3 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (11)
Emergency Department Boarding and Mortality: A Systematic Review and Proportional Meta‐Analysis
Background and Aims: Emergency department (ED) crowding, worsened by ED boarding (EDB), is defined as the stay of admitted patients in the emergency department due to the unavailability of inpatient beds. This occurrence poses a significant public health challenge, leading to adverse patient outcomes. Despite efforts to improve patient care pathways, the relationship between EDB and mortality is still contentious. This study aims to synthesize and compare reported in‐hospital mortality (IHM) among ED patients across studies stratified by ED boarding duration thresholds, with particular attention to shorter boarding durations. Methods: A systematic review and proportional meta‐analysis were conducted following PRISMA guidelines. MEDLINE, EMBASE, Web of Science, and Scopus were searched up to April 2024. Pooled mortality proportions were estimated using random‐effects models with DerSimonian–Laird estimation and Freeman–Tukey double arcsine transformation. Heterogeneity was assessed using I 2 . Leave‐one‐out analyses were performed to assess the robustness of subgroup estimates, with particular attention to longer boarding thresholds. Results: Twenty studies published between 2007 and 2024 were included. The overall pooled in‐hospital mortality proportion was 8.3% (95% CI: 7.6%–9.0%; I 2 = 99.9%). Subgroup analyses showed pooled mortality estimates of 10.2% for early admission/no boarding, 4.4% for 1‐h boarding, 5.9% for 2‐h boarding, 4.8% for 4‐h boarding, 13.5% for 6‐h boarding, 20.5% for 8‐h boarding, 21.8% for 12‐h boarding, and 11.8% for 24‐h boarding. Shorter boarding thresholds were not associated with higher pooled mortality estimates compared with early admission/no boarding. Although longer boarding thresholds showed higher pooled mortality estimates, the 8‐, 12‐, and 24‐h subgroup estimates were based on few studies and were materially influenced by Verma et al. 2021. After excluding this study, the pooled mortality estimates decreased to 7.9%, 3.9%, and 4.0% for the 8‐, 12‐, and 24‐h subgroups, respectively. Given the extreme heterogeneity, these pooled estimates require cautious interpretation. Because different studies contributed to different threshold‐specific pools, the estimates are descriptive and should not be interpreted as evidence of a threshold or dose‐response relationship. Conclusion: This study highlights the possible association between prompt admissions, targeted interventions, and outcomes in the context of ED boarding. Improving ED operations and reducing boarding times within these durations remain important organizational objectives. Further research with standardized methodologies is essential to fully understand and address this complex issue. However, the present pooled proportions do not establish a boarding‐duration threshold, dose‐response relationship, or causal association, and their interpretation is limited by extreme heterogeneity (I 2 = 99.9%).
- 4 November 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (11)
Open AccessEmergency Department Boarding and Mortality: A Systematic Review and Proportional Meta‐Analysis
Background and Aims: Emergency department (ED) crowding, worsened by ED boarding (EDB), is defined as the stay of admitted patients in the emergency department due to the unavailability of inpatient beds. This occurrence poses a significant public health challenge, leading to adverse patient outcomes. Despite efforts to improve patient care pathways, the relationship between EDB and mortality is still contentious. This study aims to synthesize and compare reported in‐hospital mortality (IHM) among ED patients across studies stratified by ED boarding duration thresholds, with particular attention to shorter boarding durations. Methods: A systematic review and proportional meta‐analysis were conducted following PRISMA guidelines. MEDLINE, EMBASE, Web of Science, and Scopus were searched up to April 2024. Pooled mortality proportions were estimated using random‐effects models with DerSimonian–Laird estimation and Freeman–Tukey double arcsine transformation. Heterogeneity was assessed using I 2 . Leave‐one‐out analyses were performed to assess the robustness of subgroup estimates, with particular attention to longer boarding thresholds. Results: Twenty studies published between 2007 and 2024 were included. The overall pooled in‐hospital mortality proportion was 8.3% (95% CI: 7.6%–9.0%; I 2 = 99.9%). Subgroup analyses showed pooled mortality estimates of 10.2% for early admission/no boarding, 4.4% for 1‐h boarding, 5.9% for 2‐h boarding, 4.8% for 4‐h boarding, 13.5% for 6‐h boarding, 20.5% for 8‐h boarding, 21.8% for 12‐h boarding, and 11.8% for 24‐h boarding. Shorter boarding thresholds were not associated with higher pooled mortality estimates compared with early admission/no boarding. Although longer boarding thresholds showed higher pooled mortality estimates, the 8‐, 12‐, and 24‐h subgroup estimates were based on few studies and were materially influenced by Verma et al. 2021. After excluding this study, the pooled mortality estimates decreased to 7.9%, 3.9%, and 4.0% for the 8‐, 12‐, and 24‐h subgroups, respectively. Given the extreme heterogeneity, these pooled estimates require cautious interpretation. Because different studies contributed to different threshold‐specific pools, the estimates are descriptive and should not be interpreted as evidence of a threshold or dose‐response relationship. Conclusion: This study highlights the possible association between prompt admissions, targeted interventions, and outcomes in the context of ED boarding. Improving ED operations and reducing boarding times within these durations remain important organizational objectives. Further research with standardized methodologies is essential to fully understand and address this complex issue. However, the present pooled proportions do not establish a boarding‐duration threshold, dose‐response relationship, or causal association, and their interpretation is limited by extreme heterogeneity (I 2 = 99.9%).
- Open Access
- 1 January 2026
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2026 (1) , 2551074
Assessing the Safety and Value of Electrochemotherapy: A Comprehensive Umbrella Review
Background: Electrochemotherapy (ECT) is a nonthermal locoregional treatment that enhances cytotoxic drug uptake through reversible electroporation and is increasingly used across different malignancies. Despite consistent evidence of clinical efficacy, uncertainties remain regarding its safety profile in heterogeneous clinical settings. This umbrella review synthesizes and critically appraises the available evidence on the efficacy and safety of ECT in oncological patients to inform clinical practice and future research. Methods: An umbrella review of systematic reviews and meta‐analyses was conducted in accordance with PRISMA and Joanna Briggs Institute guidance and registered in PROSPERO. Methodological quality and overlap were assessed using AMSTAR‐2 and the corrected covered area. Random‐effects meta‐analyses were performed to estimate pooled response and adverse event proportions, with subgroup and robustness analyses. Results: A total of 11 secondary studies were included. The pooled overall response rate to ECT was 78.6% (95% CI: 71.9%–84.0%) under a random‐effects model, with substantial heterogeneity across studies ( I 2 = 88.2%). Subgroup analyses showed variability in overall response according to tumor type and treatment intent; however, no statistically significant between‐group differences were observed. The pooled proportion of adverse effects was 10% (95% CI: 0.0%–43.1%), with extreme between‐study heterogeneity ( I 2 = 99.5%). Most reported adverse events were local and mild, whereas severe or systemic toxicities were uncommon. Conclusions: ECT is an effective locoregional treatment with high antitumor activity across multiple oncological indications. While safety outcomes were predominantly local and mild, interpretation of pooled toxicity estimates should account for variability in adverse event reporting. Overall consistent response patterns underscore its clinical relevance; however, further high‐quality prospective studies and standardized reporting are needed to guide broader implementation.
- 1 January 2026
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2026 (1) , 2551074
Open AccessAssessing the Safety and Value of Electrochemotherapy: A Comprehensive Umbrella Review
Background: Electrochemotherapy (ECT) is a nonthermal locoregional treatment that enhances cytotoxic drug uptake through reversible electroporation and is increasingly used across different malignancies. Despite consistent evidence of clinical efficacy, uncertainties remain regarding its safety profile in heterogeneous clinical settings. This umbrella review synthesizes and critically appraises the available evidence on the efficacy and safety of ECT in oncological patients to inform clinical practice and future research. Methods: An umbrella review of systematic reviews and meta‐analyses was conducted in accordance with PRISMA and Joanna Briggs Institute guidance and registered in PROSPERO. Methodological quality and overlap were assessed using AMSTAR‐2 and the corrected covered area. Random‐effects meta‐analyses were performed to estimate pooled response and adverse event proportions, with subgroup and robustness analyses. Results: A total of 11 secondary studies were included. The pooled overall response rate to ECT was 78.6% (95% CI: 71.9%–84.0%) under a random‐effects model, with substantial heterogeneity across studies ( I 2 = 88.2%). Subgroup analyses showed variability in overall response according to tumor type and treatment intent; however, no statistically significant between‐group differences were observed. The pooled proportion of adverse effects was 10% (95% CI: 0.0%–43.1%), with extreme between‐study heterogeneity ( I 2 = 99.5%). Most reported adverse events were local and mild, whereas severe or systemic toxicities were uncommon. Conclusions: ECT is an effective locoregional treatment with high antitumor activity across multiple oncological indications. While safety outcomes were predominantly local and mild, interpretation of pooled toxicity estimates should account for variability in adverse event reporting. Overall consistent response patterns underscore its clinical relevance; however, further high‐quality prospective studies and standardized reporting are needed to guide broader implementation.
- 10 November 2025
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (3) , 1329-1339
Potential Role of Botulinum Neurotoxin Type A as a Supportive Intervention for Depressive Symptoms: A Systematic Review
Background Depression is a major global health issue. Recent studies suggest that botulinum toxin (BoNT/A), commonly used in aesthetic procedures, might have potential as an adjunct to traditional treatments for depressive symptoms. It is hypothesized that BoNT/A could influence neurochemical pathways to help alleviate depressive symptoms. Methods A systematic literature review was conducted focusing on Botulinum Neurotoxin Type A (BoNT/A) for depressive disorders. Primary studies published in English were included. Data were extracted on injection sites, dosage, adverse events, and outcomes. Statistical analysis included chi-squared tests and logistic regression to identify treatment predictors. Results Twelve studies were included, primarily targeting the glabellar region with BoNT/A injections. Approximately 71% of patients demonstrated reductions in depression symptoms. The chi-square test revealed a significant association between injection sites and depression improvement (p = 0.009). Higher doses of BoNT/A showed a marginally negative relationship with depression reduction (p = 0.098). Most adverse effects were mild, such as local site reactions and mild headaches, with no severe adverse events like suicidal ideation reported. Conclusions This review describes the possible use of BoNT/A as an adjunct therapy for depressive symptoms, particularly when targeting facial muscles. Further research is needed to optimize dosage and explore the neurobiological mechanisms involved to improve therapeutic outcomes. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 10 November 2025
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (3) , 1329-1339
Potential Role of Botulinum Neurotoxin Type A as a Supportive Intervention for Depressive Symptoms: A Systematic Review
Background Depression is a major global health issue. Recent studies suggest that botulinum toxin (BoNT/A), commonly used in aesthetic procedures, might have potential as an adjunct to traditional treatments for depressive symptoms. It is hypothesized that BoNT/A could influence neurochemical pathways to help alleviate depressive symptoms. Methods A systematic literature review was conducted focusing on Botulinum Neurotoxin Type A (BoNT/A) for depressive disorders. Primary studies published in English were included. Data were extracted on injection sites, dosage, adverse events, and outcomes. Statistical analysis included chi-squared tests and logistic regression to identify treatment predictors. Results Twelve studies were included, primarily targeting the glabellar region with BoNT/A injections. Approximately 71% of patients demonstrated reductions in depression symptoms. The chi-square test revealed a significant association between injection sites and depression improvement (p = 0.009). Higher doses of BoNT/A showed a marginally negative relationship with depression reduction (p = 0.098). Most adverse effects were mild, such as local site reactions and mild headaches, with no severe adverse events like suicidal ideation reported. Conclusions This review describes the possible use of BoNT/A as an adjunct therapy for depressive symptoms, particularly when targeting facial muscles. Further research is needed to optimize dosage and explore the neurobiological mechanisms involved to improve therapeutic outcomes. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- Open Access
- 10 January 2025
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 15 (1) , 25
Health Professionals’ Preferences for Next-Generation Sequencing in the Diagnosis of Suspected Genetic Disorders in the Paediatric Population
Background/Objectives: Next-generation sequencing (NGS) can explain how genetics influence morbidity and mortality in children. However, it is unclear whether health providers will perceive and use such treatments. We conducted a discrete choice experiment (DCE) to understand Italian health professionals’ preferences for NGS to improve the diagnosis of paediatric genetic diseases. Methods: The DCE was administered online to 125 health professionals in Italy. We documented attributes influencing professionals’ decisions of NGS, including higher diagnostic yield, shorter counselling periods, cost, turnaround time, and the identification of fewer variants of unknown significance. Results: Results show that factors such as higher diagnostic yield, shorter counselling periods, lower costs, and faster turnaround times positively influenced the adoption of NGS tests. Willingness to pay (WTP) estimates varied from EUR 387 (95% CI, 271.8–502.9) for 7% increase in the diagnostic yield to EUR 469 (95% CI, 287.2–744.9) for a decrease of one week in the turnaround time. Responders would reduce diagnostic yield by 7% to decrease the turnaround time by one week in both the preference and the willingness to trade (WTT) spaces. Respondents prioritised diagnostic yield (RI = 50.36%; 95% CI 40.2–67.2%) compared to other attributes. Conclusions: therefore, health professionals value NGS for allowing earlier, more accurate genetic diagnoses.
- 10 January 2025
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 15 (1) , 25
Open AccessHealth Professionals’ Preferences for Next-Generation Sequencing in the Diagnosis of Suspected Genetic Disorders in the Paediatric Population
Background/Objectives: Next-generation sequencing (NGS) can explain how genetics influence morbidity and mortality in children. However, it is unclear whether health providers will perceive and use such treatments. We conducted a discrete choice experiment (DCE) to understand Italian health professionals’ preferences for NGS to improve the diagnosis of paediatric genetic diseases. Methods: The DCE was administered online to 125 health professionals in Italy. We documented attributes influencing professionals’ decisions of NGS, including higher diagnostic yield, shorter counselling periods, cost, turnaround time, and the identification of fewer variants of unknown significance. Results: Results show that factors such as higher diagnostic yield, shorter counselling periods, lower costs, and faster turnaround times positively influenced the adoption of NGS tests. Willingness to pay (WTP) estimates varied from EUR 387 (95% CI, 271.8–502.9) for 7% increase in the diagnostic yield to EUR 469 (95% CI, 287.2–744.9) for a decrease of one week in the turnaround time. Responders would reduce diagnostic yield by 7% to decrease the turnaround time by one week in both the preference and the willingness to trade (WTT) spaces. Respondents prioritised diagnostic yield (RI = 50.36%; 95% CI 40.2–67.2%) compared to other attributes. Conclusions: therefore, health professionals value NGS for allowing earlier, more accurate genetic diagnoses.
- Open Access
- 3 June 2024
- Published by Springer Nature in Social Indicators Research
- Vol. 173 (3) , 691-708
The Impact of Socio-Economic Conditions on Individuals’ Health: Development of an Index and Examination of its Association with Three of the Most Frequently Registered Diseases in Lazio Region of Italy
This study examines spatial disparities and associations between the social deprivation index (SDI) and Type 2 Diabetes, Dementia, and Heart Failure in Italy’s Lazio Region. The primary goal is to assess how social deprivation impacts health inequalities by analysing SDI-disease correlations. This retrospective study uses 2020 socioeconomic data and 2021 epidemiological indicators in Lazio Region, Italy. The SDI, constructed following established guidelines, measures social deprivation. Statistical tools, including regression models, Moran’s I test, and LISA techniques, are used to analyse spatial patterns. Utilizing a retrospective approach, we merge 2020 socioeconomic and 2021 epidemiological data for analysis. The SDI is computed using established methods. Spatial disparities are explored through regression models, Moran’s I test, and LISA techniques. The study reveals significant disparities in disease incidence. District V in Rome exhibits high Type 2 Diabetes (113.75/1000) and Heart Failure (37.98/1000) rates, while Marcetelli has elevated Dementia incidence (19.74). Southern municipalities face high unemployment (up to 25%), whereas bordering areas have higher education levels (30–60%). Disease hotspots emerge in Rome and centre-north municipalities, aligning with social deprivation patterns. Regression models confirm the link between disease incidence and socioeconomic indicators. SDI ranges from − 1.31 to + 10.01. This study underscores a correlation between social deprivation and disease incidence. Further national-level research is essential to deepen our understanding of how social deprivation influences health outcomes, with potential implications for addressing health disparities both regionally and nationally.
- 3 June 2024
- Published by Springer Nature in Social Indicators Research
- Vol. 173 (3) , 691-708
Open AccessThe Impact of Socio-Economic Conditions on Individuals’ Health: Development of an Index and Examination of its Association with Three of the Most Frequently Registered Diseases in Lazio Region of Italy
This study examines spatial disparities and associations between the social deprivation index (SDI) and Type 2 Diabetes, Dementia, and Heart Failure in Italy’s Lazio Region. The primary goal is to assess how social deprivation impacts health inequalities by analysing SDI-disease correlations. This retrospective study uses 2020 socioeconomic data and 2021 epidemiological indicators in Lazio Region, Italy. The SDI, constructed following established guidelines, measures social deprivation. Statistical tools, including regression models, Moran’s I test, and LISA techniques, are used to analyse spatial patterns. Utilizing a retrospective approach, we merge 2020 socioeconomic and 2021 epidemiological data for analysis. The SDI is computed using established methods. Spatial disparities are explored through regression models, Moran’s I test, and LISA techniques. The study reveals significant disparities in disease incidence. District V in Rome exhibits high Type 2 Diabetes (113.75/1000) and Heart Failure (37.98/1000) rates, while Marcetelli has elevated Dementia incidence (19.74). Southern municipalities face high unemployment (up to 25%), whereas bordering areas have higher education levels (30–60%). Disease hotspots emerge in Rome and centre-north municipalities, aligning with social deprivation patterns. Regression models confirm the link between disease incidence and socioeconomic indicators. SDI ranges from − 1.31 to + 10.01. This study underscores a correlation between social deprivation and disease incidence. Further national-level research is essential to deepen our understanding of how social deprivation influences health outcomes, with potential implications for addressing health disparities both regionally and nationally.
- Open Access
- 1 October 2023
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 33 (Supplement)
Counting the Cost: The Economic Toll of Discrimination Against LGBTQAI+ Individuals in Italy
This study investigates the financial consequences of perceived discrimination towards LGBTQAI+ people in Italy, focusing on psychological support and medication costs. It highlights the burden of discriminatory experiences, emphasizing the need for policies to minimize costs. A cost analysis was performed according to the NHS perspective. A purposive sample was recruited through a web-based survey spread on Italian researchers’ social networks, asking any LGBTQAI+ readers to answer about discriminatory experiences, access to psychological support, and medication use. Costs of health services use were estimated according to the Italian NHS tariffs and Italian Psychologists’ Board. The time horizon was set at one year and discounting was not necessary. Robustness was checked by a one-way sensitivity analysis. A total of 75 LGBTQAI+ people completed the survey. Most of them (aged 26-35 years, 85%; residing in big cities, 70%; unaffiliated with LGBTQAI+ associations, 88%) reported discriminative actions (60%), with 15% seeking psychological help soon after being victim of a single discriminatory act. Verbal and physical abuse were reported by 88% and 6% respectively. 40% of respondents claimed to have resorted to psychotherapy sessions because of the discomfort felt after acts perceived as discriminatory or violent, amounting to 810 total therapy hours. The total therapy cost was €72,900, of which 60% paid as out-of-pocket expenses, and 40% partially covered by regional Local Health Units. Additionally, 12% of respondents used SSRI or benzodiazepines, costing the National Health System an esteemed €3054. The sensitive analysis confirmed the robustness of results. The study demonstrates the significant economic burden of discrimination against LGBTQAI+ individuals in Italy, emphasizing the need for inclusive policies and accessible mental health support. Further research is required to explore indirect costs, for a comprehensive understanding of the total economic impact. Key messages: • Discrimination against LGBTQAI+ individuals in Italy causes significant financial burden due to costs of psychological support and medication. • Inclusive policies and accessible mental health support are needed to address the economic impact of discrimination against LGBTQAI+ individuals in Italy.
- 1 October 2023
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 33 (Supplement)
Open AccessCounting the Cost: The Economic Toll of Discrimination Against LGBTQAI+ Individuals in Italy
This study investigates the financial consequences of perceived discrimination towards LGBTQAI+ people in Italy, focusing on psychological support and medication costs. It highlights the burden of discriminatory experiences, emphasizing the need for policies to minimize costs. A cost analysis was performed according to the NHS perspective. A purposive sample was recruited through a web-based survey spread on Italian researchers’ social networks, asking any LGBTQAI+ readers to answer about discriminatory experiences, access to psychological support, and medication use. Costs of health services use were estimated according to the Italian NHS tariffs and Italian Psychologists’ Board. The time horizon was set at one year and discounting was not necessary. Robustness was checked by a one-way sensitivity analysis. A total of 75 LGBTQAI+ people completed the survey. Most of them (aged 26-35 years, 85%; residing in big cities, 70%; unaffiliated with LGBTQAI+ associations, 88%) reported discriminative actions (60%), with 15% seeking psychological help soon after being victim of a single discriminatory act. Verbal and physical abuse were reported by 88% and 6% respectively. 40% of respondents claimed to have resorted to psychotherapy sessions because of the discomfort felt after acts perceived as discriminatory or violent, amounting to 810 total therapy hours. The total therapy cost was €72,900, of which 60% paid as out-of-pocket expenses, and 40% partially covered by regional Local Health Units. Additionally, 12% of respondents used SSRI or benzodiazepines, costing the National Health System an esteemed €3054. The sensitive analysis confirmed the robustness of results. The study demonstrates the significant economic burden of discrimination against LGBTQAI+ individuals in Italy, emphasizing the need for inclusive policies and accessible mental health support. Further research is required to explore indirect costs, for a comprehensive understanding of the total economic impact. Key messages: • Discrimination against LGBTQAI+ individuals in Italy causes significant financial burden due to costs of psychological support and medication. • Inclusive policies and accessible mental health support are needed to address the economic impact of discrimination against LGBTQAI+ individuals in Italy.
- Open Access
- 26 May 2023
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (6) , 899
Organizational Aspects of the Implementation and Use of Whole Genome Sequencing and Whole Exome Sequencing in the Pediatric Population in Italy: Results of a Survey
This study explores the organizational aspects of whole genome sequencing (WGS) implementation for pediatric patients with suspected genetic disorders in Italy, comparing it with whole exome sequencing (WES). Health professionals’ opinions were collected through an internet-based survey and analyzed using a qualitative summative content analysis methodology. Among the 16 respondents, most were clinical geneticists performing only WES, while 5 also used WGS. The key differences identified include higher needs for analyzing genome rearrangements following WES, greater data storage and security requirements for WGS, and WGS only being performed in specific research studies. No difference was detected in centralization and decentralization issues. The main cost factors included genetic consultations, library preparation and sequencing, bioinformatic analysis, interpretation and confirmation, data storage, and complementary diagnostic investigations. Both WES and WGS decreased the need for additional diagnostic analyses when not used as last-resort tests. Organizational aspects were similar for WGS and WES, but economic evidence gaps may exist for WGS in clinical settings. As sequencing costs decline, WGS will likely replace WES and traditional genetic testing. Tailored genomic policies and cost-effectiveness analyses are needed for WGS implementation in health systems. WGS shows promise for enhancing genetics knowledge and expediting diagnoses for pediatric patients with genetic disorders.
- 26 May 2023
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (6) , 899
Open AccessOrganizational Aspects of the Implementation and Use of Whole Genome Sequencing and Whole Exome Sequencing in the Pediatric Population in Italy: Results of a Survey
This study explores the organizational aspects of whole genome sequencing (WGS) implementation for pediatric patients with suspected genetic disorders in Italy, comparing it with whole exome sequencing (WES). Health professionals’ opinions were collected through an internet-based survey and analyzed using a qualitative summative content analysis methodology. Among the 16 respondents, most were clinical geneticists performing only WES, while 5 also used WGS. The key differences identified include higher needs for analyzing genome rearrangements following WES, greater data storage and security requirements for WGS, and WGS only being performed in specific research studies. No difference was detected in centralization and decentralization issues. The main cost factors included genetic consultations, library preparation and sequencing, bioinformatic analysis, interpretation and confirmation, data storage, and complementary diagnostic investigations. Both WES and WGS decreased the need for additional diagnostic analyses when not used as last-resort tests. Organizational aspects were similar for WGS and WES, but economic evidence gaps may exist for WGS in clinical settings. As sequencing costs decline, WGS will likely replace WES and traditional genetic testing. Tailored genomic policies and cost-effectiveness analyses are needed for WGS implementation in health systems. WGS shows promise for enhancing genetics knowledge and expediting diagnoses for pediatric patients with genetic disorders.
- Open Access
- 25 May 2023
- Published by Springer Nature in Archives of Public Health
- Vol. 81 (1) , 1-12
Whole genome sequencing diagnostic yield for paediatric patients with suspected genetic disorders: systematic review, meta-analysis, and GRADE assessment
Background: About 80% of the roughly 7,000 known rare diseases are single gene disorders, about 85% of which are ultra-rare, affecting less than one in one million individuals. NGS technologies, in particular whole genome sequencing (WGS) in paediatric patients suffering from severe disorders of likely genetic origin improve the diagnostic yield allowing targeted, effective care and management. The aim of this study is to perform a systematic review and meta-analysis to assess the effectiveness of WGS, with respect to whole exome sequencing (WES) and/or usual care, for the diagnosis of suspected genetic disorders among the paediatric population.Methods: A systematic review of the literature was conducted querying relevant electronic databases, including MEDLINE, EMBASE, ISI Web of Science, and Scopus from January 2010 to June 2022. A random-effect meta-analysis was run to inspect the diagnostic yield of different techniques. A network meta-analysis was also performed to directly assess the comparison between WGS and WES.Results: Of the 4,927 initially retrieved articles, thirty-nine met the inclusion criteria. Overall results highlighted a significantly higher pooled diagnostic yield for WGS, 38.6% (95% CI: [32.6 – 45.0]), in respect to WES, 37.8% (95% CI: [32.9 – 42.9]) and usual care, 7.8% (95% CI: [4.4 – 13.2]). The meta-regression output suggested a higher diagnostic yield of the WGS compared to WES after controlling for the type of disease (monogenic vs non-monogenic), with a tendency to better diagnostic performances for Mendelian diseases. The network meta-analysis showed a higher diagnostic yield for WGS compared to WES (OR = 1.54, 95%CI: [1.11 – 2.12]).Conclusions: Although whole genome sequencing for the paediatric population with suspected genetic disorders provided an accurate and early genetic diagnosis in a high proportion of cases, further research is needed for evaluating costs, effectiveness, and cost-effectiveness of WGS and achieving an informed decision-making process.Trial Registration: This systematic review has not been registered.
- 25 May 2023
- Published by Springer Nature in Archives of Public Health
- Vol. 81 (1) , 1-12
Open AccessWhole genome sequencing diagnostic yield for paediatric patients with suspected genetic disorders: systematic review, meta-analysis, and GRADE assessment
Background: About 80% of the roughly 7,000 known rare diseases are single gene disorders, about 85% of which are ultra-rare, affecting less than one in one million individuals. NGS technologies, in particular whole genome sequencing (WGS) in paediatric patients suffering from severe disorders of likely genetic origin improve the diagnostic yield allowing targeted, effective care and management. The aim of this study is to perform a systematic review and meta-analysis to assess the effectiveness of WGS, with respect to whole exome sequencing (WES) and/or usual care, for the diagnosis of suspected genetic disorders among the paediatric population.Methods: A systematic review of the literature was conducted querying relevant electronic databases, including MEDLINE, EMBASE, ISI Web of Science, and Scopus from January 2010 to June 2022. A random-effect meta-analysis was run to inspect the diagnostic yield of different techniques. A network meta-analysis was also performed to directly assess the comparison between WGS and WES.Results: Of the 4,927 initially retrieved articles, thirty-nine met the inclusion criteria. Overall results highlighted a significantly higher pooled diagnostic yield for WGS, 38.6% (95% CI: [32.6 – 45.0]), in respect to WES, 37.8% (95% CI: [32.9 – 42.9]) and usual care, 7.8% (95% CI: [4.4 – 13.2]). The meta-regression output suggested a higher diagnostic yield of the WGS compared to WES after controlling for the type of disease (monogenic vs non-monogenic), with a tendency to better diagnostic performances for Mendelian diseases. The network meta-analysis showed a higher diagnostic yield for WGS compared to WES (OR = 1.54, 95%CI: [1.11 – 2.12]).Conclusions: Although whole genome sequencing for the paediatric population with suspected genetic disorders provided an accurate and early genetic diagnosis in a high proportion of cases, further research is needed for evaluating costs, effectiveness, and cost-effectiveness of WGS and achieving an informed decision-making process.Trial Registration: This systematic review has not been registered.
- Open Access
- 27 April 2023
- Published by European Publishing in Population Medicine
- Vol. 5 (Supplement)
The impact of Long COVID Syndrome treatment and rehabilitation: systematic review and meta-analysis of patient-reported outcomes
Background and Objective: COVID-19 pandemic resulted in an unprecedented public health crisis, in which efforts mostly focused on containment and treatment of acute disease. However, important disease sequelae are increasingly reported by clinicians and addressed in terms of treatment and...
- 27 April 2023
- Published by European Publishing in Population Medicine
- Vol. 5 (Supplement)
Open AccessThe impact of Long COVID Syndrome treatment and rehabilitation: systematic review and meta-analysis of patient-reported outcomes
Background and Objective: COVID-19 pandemic resulted in an unprecedented public health crisis, in which efforts mostly focused on containment and treatment of acute disease. However, important disease sequelae are increasingly reported by clinicians and addressed in terms of treatment and...
- Open Access
- 26 April 2023
- Published by European Publishing in Population Medicine
- Vol. 5 (Supplement)
Human factor on data safety: Resident doctors attitude towards cybersecurity on the workplace
New health technologies bring hope for a better and more efficient process of care. However, the use of new instruments entails new doubts on efficacy and safety. Verizons 2018 Data Breach Investigation Report found out that the healthcare sector was the most affected one by personal data...
- 26 April 2023
- Published by European Publishing in Population Medicine
- Vol. 5 (Supplement)
Open AccessHuman factor on data safety: Resident doctors attitude towards cybersecurity on the workplace
New health technologies bring hope for a better and more efficient process of care. However, the use of new instruments entails new doubts on efficacy and safety. Verizons 2018 Data Breach Investigation Report found out that the healthcare sector was the most affected one by personal data...